Search Nonprofits

The mission of the Kosten foundation is four-fold:To establish support and a forum for communication amongst those afflicted with pancreatic cancer via support group meetings and this website.To assist with the training of future pancreatic surgeons.To provide funding for a yearly Memphis public lecture on pancreatic cancer delivered by a nationally and/or internationally renowned expert on the disease.To provide funding for clinical and basic research toward improving outcomes of those afflicted with pancreatic cancer.

To ease suffering, provide hope, and save lives of people stricken with cancer

Founded in 1947, Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and adults with cancer, while advancing the understanding, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations and disseminates innovative patient therapies and scientific discoveries in Boston, across the United States and throughout the world.

Nancy G. Brinker promised her sister that she would do everything in her power to end breast cancer forever. That promise is now Susan G. Komen for the Cure®, the global leader of the breast cancer movement, having invested more than $2.2 billion since inception in 1982. As the world’s largest grassroots network of breast cancer survivors and activists, we’re working together to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Susan G. Komen Race for the Cure® and the Susan G. Komen 3-Day for the Cure®, and generous contributions from our partners, sponsors and fellow supporters, we have become the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.

The Breast Cancer Research Foundation (BCRF) is dedicated to being the end of breast cancer by advancing the world's most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment and survivorship. This year, BCRF has awarded $63 million in grants to support the work of nearly 300 scientists at leading medical and academic institutions across 14 countries, making BCRF the largest private funder of breast cancer research worldwide. BCRF is also the highest rated breast cancer organization in the U.S. Visit www.bcrf.org to learn more.

Memorial Sloan-Kettering Cancer Center is dedicated to leading the fight against cancer, individually focusing on each patient and creating an impact on cancer treatment and the biomedical research agenda around the world. As one of the world's premier cancer centers, Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between its physicians and scientists is one of its unique strengths, enabling it to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future.

The Leukemia and Lymphoma Society (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we've invested more than $1.6 billion in groundbreaking research, pioneering many of today's most innovative approaches. LLS provides free information and support services for patients, survivors, families and healthcare professionals, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care through an advocacy network of over 100,000 volunteers at the state and federal level.

The Carol M. Baldwin Breast Cancer Research Fund, Inc., supports both new and established researchers at University Hospital and Medical Center at the State University of New York at Stony Brook, and other outstanding academic institutions, investigating the causes, prevention and treatment of breast cancer. This research will include-but not be limited to-studies of the genetic, molecular, cellular and environmental factors involved in the development and progression of breast cancer; application of the knowledge thus gained to educate medical professionals and increase public awareness for the prevention, detection and treatment of breast cancer; and studies of the outcomes of breast cancer detection and treatment on the patient, their families and society.

TO SUPPORT RESEARCH AND PROGRAMS DESIGNED TO REDUCE THE MORBIDITY AND MORTALITY FROM WOMEN'S CANCERS AS WELL AS IMPROVE THE QUALITY OF LIFE FOR WOMEN AFFLICTED WITH CANCER